Skip to main content
SpringerLink
Log in

Medical Evaluation of the Living Donor for Pediatric Kidney Transplantation

  • Chapter
  • First Online:
Pediatric Solid Organ Transplantation

  • 464 Accesses

Abstract

The optimal and most cost-effective modality of kidney replacement therapy is kidney transplantation [1]. It provides superior patient outcomes and significantly more quality of life than dialysis for the treatment of end-stage kidney disease (ESKD). The demand for transplants continues to rise. The kidney waiting list is about sixfold greater than the number of transplants performed [2]. Increasing the available pool of grafts is becoming a necessity. Living donor transplantation is an ideal option due to increased waiting time across transplant centers in the United States (US) for deceased donor transplantation and superior graft and patient survival **.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, Hays R, Howard A, Jones E, Leichtman AB, Merion RM, Metzger RA, Pradel F, Schweitzer EJ, Velez RL, Gaston RS. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/kidney disease outcomes quality initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol. 2008;3(2):471–80. https://doi.org/10.2215/CJN.05021107. Epub 2008 Feb 6. PMID: 18256371; PMCID: PMC2390948

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lentine KL, Smith JM, Hart A, Miller J, Skeans MA, Larkin L, Robinson A, Gauntt K, Israni AK, Hirose R, Snyder JJ. OPTN/SRTR 2020 annual data report: kidney. Am J Transplant. 2022;22(Suppl 2):21–136. https://doi.org/10.1111/ajt.16982.

    Article  PubMed  Google Scholar 

  3. Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberú J, Bakr MA, Gallon L, Garvey CA, Guleria S, Li PK, Segev DL, Taler SJ, Tanabe K, Wright L, Zeier MG, Cheung M, Garg AX. KDIGO clinical practice guideline on the evaluation and Care of Living Kidney Donors. Transplantation. 2017;101(8S Suppl 1):S1–S109. https://doi.org/10.1097/TP.0000000000001769. PMID: 28742762; PMCID: PMC5540357

    Article  PubMed  Google Scholar 

  4. Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL, Segev DL. Risk of end-stage renal disease following live kidney donation. JAMA. 2014;311(6):579–86. https://doi.org/10.1001/jama.2013.285141. PMID: 24519297; PMCID: PMC4411956

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H. Long-term risks for kidney donors. Kidney Int. 2014;86(1):162–7. https://doi.org/10.1038/ki.2013.460. Epub 2013 Nov 27. PMID: 24284516.

    Article  PubMed  Google Scholar 

  6. Claisse G, Gaillard F, Mariat C. Living kidney donor evaluation. Transplantation. 2020;104(12):2487–96. https://doi.org/10.1097/TP.0000000000003242.

    Article  PubMed  Google Scholar 

  7. Tong A, Chapman JR, Wong G, de Bruijn J, Craig JC. Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation. 2011;92(9):962–72. https://doi.org/10.1097/TP.0b013e3182328276.

    Article  PubMed  Google Scholar 

  8. Sawinski D, Locke JE. Evaluation of kidney donors: Core curriculum. Am J Kidney Dis. 2018;71(5):737–47.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lenihan CR, Busque S, Derby G, Blouch K, Myers BD, Tan JC. Longitudinal study of living kidney donor glomerular dynamics after nephrectomy. J Clin Invest. 2015;125(3):1311–8. https://doi.org/10.1172/JCI78885. Epub 2015 Feb 17. PMID: 25689253; PMCID: PMC4362245

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kasiske BL, Anderson-Haag T, Israni AK, Kalil RS, Kimmel PL, Kraus ES, Kumar R, Posselt AA, Pesavento TE, Rabb H, Steffes MW, Snyder JJ, Weir MR. A prospective controlled study of living kidney donors: three-year follow-up. Am J Kidney Dis. 2015;66(1):114–24. https://doi.org/10.1053/j.ajkd.2015.01.019. Epub 2015 Mar 17. PMID: 25795073; PMCID: PMC4485526

    Article  PubMed  PubMed Central  Google Scholar 

  11. Garg AX, Prasad GV, Thiessen-Philbrook HR, Ping L, Melo M, Gibney EM, Knoll G, Karpinski M, Parikh CR, Gill J, Storsley L, Donor Nephrectomy Outcomes Research (DONOR) Network. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation. 2008;86(3):399–406. https://doi.org/10.1097/TP.0b013e31817ba9e3.

    Article  PubMed  Google Scholar 

  12. Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC, Rosas-Arellano MP, Housawi A, Garg AX. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med. 2006;145(3):185–96.

    Article  PubMed  Google Scholar 

  13. Kasiske BL, Ma JZ, Louis TA, Swan SK. Long-term effects of reduced renal mass in humans. Kidney Int. 1995;48(3):814–9. https://doi.org/10.1038/ki.1995.355.

    Article  CAS  PubMed  Google Scholar 

  14. Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D. Glycemic status and development of kidney disease: the Framingham heart study. Diabetes Care. 2005;28(10):2436–40. https://doi.org/10.2337/diacare.28.10.2436.

    Article  PubMed  Google Scholar 

  15. Okamoto M, Suzuki T, Fujiki M, Nobori S, Ushigome H, Sakamoto S, Yoshimura N. The Consequences for Live Kidney Donors with Preexisting Glucose Intolerance Without Diabetic Complication: Analysis at a Single Japanese Center. Transplantation. 2010;89(11):1391–5. https://doi.org/10.1097/TP.0b013e3181d9e17b.

    Article  CAS  PubMed  Google Scholar 

  16. Anjum S, Muzaale AD, Massie AB, Bae S, Luo X, Grams ME, Lentine KL, Garg AX, Segev DL. Patterns of end-stage renal disease caused by diabetes, hypertension, and glomerulonephritis in live kidney donors. Am J Transplant. 2016;16(12):3540–7. https://doi.org/10.1111/ajt.13917.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Locke JE, Reed RD, Massie A, MacLennan PA, Sawinski D, Kumar V, Mehta S, Mannon RB, Gaston R, Lewis CE, Segev DL. Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int. 2017;91(3):699–703. https://doi.org/10.1016/j.kint.2016.10.014. Epub 2016 Dec 29. PMID: 28041626; PMCID: PMC5313335

    Article  PubMed  Google Scholar 

  18. Praga M, Hernández E, Herrero JC, Morales E, Revilla Y, Díaz-González R, Rodicio JL. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000;58(5):2111–8. https://doi.org/10.1111/j.1523-1755.2000.00384.x.

    Article  CAS  PubMed  Google Scholar 

  19. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81. https://doi.org/10.1016/S0140-6736(10)60674-5. Epub 2010 May 17. PMID: 20483451; PMCID: PMC3993088

    Article  Google Scholar 

  20. Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, De Zeeuw D, De Jong PE, Gansevoort RT. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol. 2006;17(9):2582–90. https://doi.org/10.1681/ASN.2005121352. Epub 2006 Aug 9

    Article  PubMed  Google Scholar 

  21. Lorenz EC, Lieske JC, Vrtiska TJ, Krambeck AE, Li X, Bergstralh EJ, Melton LJ 3rd, Rule AD. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant. 2011;26(8):2695–700. https://doi.org/10.1093/ndt/gfq769. Epub 2011 Feb 1. PMID: 21285126; PMCID: PMC3145914

    Article  PubMed  PubMed Central  Google Scholar 

  22. Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013;24(3):364–75. https://doi.org/10.1681/ASN.2012020148. Epub 2013 Jan 24

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Recanati/Miller Transplantation Institute, Icahn School of Medicine at Mt. Sinai, New York, NY, USA

    Fahima Mahir & Veronica Delaney

Authors
  1. Fahima Mahir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Veronica Delaney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fahima Mahir .

Editor information

Editors and Affiliations

  1. Recanati/Miller Transplantation Institute, Mount Sinai Hospital, NY, USA

    Ron Shapiro

  2. Division of Transplant Surgery, University of California, San Francisco, CA, USA

    Minnie M. Sarwal

  3. Department of Nephrology, Akron General Medical Center at Cleveland Clinic Foundation and Akron Children’s Hospital, OH, USA

    Rupesh Raina

  4. Kidney and Urology Institute, Medanta, The Medicity, Gurugram, Haryana, India

    Sidharth Kumar Sethi

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mahir, F., Delaney, V. (2023). Medical Evaluation of the Living Donor for Pediatric Kidney Transplantation. In: Shapiro, R., Sarwal, M.M., Raina, R., Sethi, S.K. (eds) Pediatric Solid Organ Transplantation. Springer, Singapore. https://doi.org/10.1007/978-981-19-6909-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-6909-6_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-6908-9

  • Online ISBN: 978-981-19-6909-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation